USNA insider buying and SEC filings, explained
Usana Health Sciences Inc. · CIK 896264
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Medicinal Chemicals & Botanical Products
- State of incorporation
- UT
- Fiscal year end
- Jan 3
- Former names
- USANA INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$991K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 16, 2026 | Sale | Brent Neidig (Chief Commercial Officer) sold 5,002 shares at about $19.45 ($97K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 12–15, 2026 | Sale | Brent Neidig (Chief Commercial Officer) sold 2,511 shares between Jun 12 and Jun 15 at about $20.10 ($50K). Holdings down 33% to 5,002 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| Jun 8, 2026 | Sale | Paul A. Jones (Chief People Officer) sold 5,561 shares at $18.50 ($103K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 8, 2026 |
| Jun 1, 2026 | Sale | John Turman Fleming (Director) sold 2,450 shares at $17.93 ($44K). Holdings down 37% to 4,230 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 1, 2026 |
| May 28, 2026 | Sale | Paul A. Jones (Chief People Officer) sold 6,813 shares at $18.95 ($129K). Holdings down 55% to 5,561 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 29, 2026 |
| May 27, 2026 | Sale | G. Doug Iiekking (CFO) sold 5,360 shares at $18.75 ($101K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| May 22, 2026 | Sale | Gilbert A. Fuller (Director) sold 1,057 shares at about $18.66 ($20K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 26, 2026 |
| May 7, 2026 | Sale | Joshua Foukas (Chief Legal Officer) sold 3,791 shares at $19.82 ($75K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 8, 2026 |
| Mar 20, 2026 | Sale | Gilbert A. Fuller (Director) sold 1,058 shares at $17.00 ($18K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 20, 2026 |
| Mar 3, 2026 | Sale | Peter Benedict (Chief Information Officer) sold 4,553 shares at about $19.38 ($88K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 20, 2026 | Sale | Joshua Foukas (Chief Legal Officer) sold 4,461 shares at $21.35 ($95K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Dec 10, 2025 | Sale | Peter Benedict (Chief Information Officer) sold 2,673 shares at $20.95 ($56K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Dec 10, 2025 | Sale | David Mulham Mulham (Chief Sales Officer) sold 873 shares at $21.00 ($18K). Holdings down 9% to 8,387 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Nov 10, 2025 | Sale | Frederic J Winssinger (Director) sold 2,000 shares at $19.21 ($38K). Holdings down 25% to 5,986 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 10, 2025 |
| Nov 3, 2025 | Sale | Gilbert A. Fuller (Director) sold 1,057 shares at $21.48 ($23K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 4, 2025 |
| Oct 31, 2025 | Sale | John Turman Fleming (Director) sold 1,750 shares at $19.79 ($35K). Holdings down 28% to 4,565 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2025 |
60 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:10 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow USNA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.